BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 17386408)

  • 1. Sinomenine attenuates 2, 4, 6-trinitrobenzene sulfonic acid-induced colitis in mice.
    Cheng H; Xia B; Guo Q; Zhang L; Wang F; Jiang L; Wang Z; Zhang Y; Li C
    Int Immunopharmacol; 2007 May; 7(5):604-11. PubMed ID: 17386408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paeonol attenuates TNBS-induced colitis by inhibiting NF-kappaB and STAT1 transactivation.
    Ishiguro K; Ando T; Maeda O; Hasegawa M; Kadomatsu K; Ohmiya N; Niwa Y; Xavier R; Goto H
    Toxicol Appl Pharmacol; 2006 Nov; 217(1):35-42. PubMed ID: 16928387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of sinomenine on the expression of microRNA-155 in 2,4,6-trinitrobenzenesulfonic acid-induced colitis in mice.
    Yu Q; Zhu S; Zhou R; Yi F; Bing Y; Huang S; Wang Z; Wang C; Xia B
    PLoS One; 2013; 8(9):e73757. PubMed ID: 24066068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curcumin regulated shift from Th1 to Th2 in trinitrobenzene sulphonic acid-induced chronic colitis.
    Zhang M; Deng CS; Zheng JJ; Xia J
    Acta Pharmacol Sin; 2006 Aug; 27(8):1071-7. PubMed ID: 16867261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changtai granule, a traditional Chinese drug, protects hapten-induced colitis by attenuating inflammatory and immune dysfunctions.
    Liu BG; Jia XM; Cao YY; Chen SH; Gao PH; Wang Y; Jiang YY; Cao YB
    J Ethnopharmacol; 2008 Jan; 115(1):1-8. PubMed ID: 17964746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preventive effects of Schistosoma japonicum ova on trinitrobenzenesulfonic acid-induced colitis and bacterial translocation in mice.
    Zhao Y; Zhang S; Jiang L; Jiang J; Liu H
    J Gastroenterol Hepatol; 2009 Nov; 24(11):1775-80. PubMed ID: 20136961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Peroxisome proliferator-activated receptor (PPAR) gamma: a new target for the treatment of inflammatory bowel disease].
    Dubuquoy L; Bourdon C; Peuchmaur M; Leibowitz MD; Nutten S; Colombel JF; Auwerx J; Desreumaux P
    Gastroenterol Clin Biol; 2000; 24(8-9):719-24. PubMed ID: 11011247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment with bindarit, an inhibitor of MCP-1 synthesis, protects mice against trinitrobenzene sulfonic acid-induced colitis.
    Bhatia M; Landolfi C; Basta F; Bovi G; Ramnath RD; de Joannon AC; Guglielmotti A
    Inflamm Res; 2008 Oct; 57(10):464-71. PubMed ID: 18827968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (Th) 1/Th17 to a Th2 and regulatory T cell profile.
    Daniel C; Sartory NA; Zahn N; Radeke HH; Stein JM
    J Pharmacol Exp Ther; 2008 Jan; 324(1):23-33. PubMed ID: 17911375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of the cholinergic anti-inflammatory pathway on experimental colitis.
    Bai A; Guo Y; Lu N
    Scand J Immunol; 2007 Nov; 66(5):538-45. PubMed ID: 17953529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The possible mechanisms of Picrasma quassiodes (D. Don) Benn. in the treatment of colitis induced by 2,4,6-trinitrobenzene sulfonic acid in mice.
    Zhao W; Sun C; He J; Chen L; Zhang Y; Sun W
    J Ethnopharmacol; 2013 Jan; 145(2):424-30. PubMed ID: 23164762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrine improves 2,4,6-trinitrobenzene sulfonic acid-induced colitis in mice.
    Cheng H; Xia B; Zhang L; Zhou F; Zhang YX; Ye M; Hu ZG; Li J; Li J; Wang ZL; Li C; Guo QS
    Pharmacol Res; 2006 Mar; 53(3):202-8. PubMed ID: 16332442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohn's disease.
    Abad C; Martinez C; Juarranz MG; Arranz A; Leceta J; Delgado M; Gomariz RP
    Gastroenterology; 2003 Apr; 124(4):961-71. PubMed ID: 12671893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin inhibits trinitrobenzene sulphonic acid-induced colitis in rats by activation of peroxisome proliferator-activated receptor gamma.
    Zhang M; Deng C; Zheng J; Xia J; Sheng D
    Int Immunopharmacol; 2006 Aug; 6(8):1233-42. PubMed ID: 16782535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Si-Ni-San, a traditional Chinese prescription, and its active ingredient glycyrrhizin ameliorate experimental colitis through regulating cytokine balance.
    Sun Y; Cai TT; Shen Y; Zhou XB; Chen T; Xu Q
    Int Immunopharmacol; 2009 Nov; 9(12):1437-43. PubMed ID: 19733696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The new low calcemic vitamin D analog 22-ene-25-oxa-vitamin D prominently ameliorates T helper cell type 1-mediated colitis in mice.
    Daniel C; Radeke HH; Sartory NA; Zahn N; Zuegel U; Steinmeyer A; Stein J
    J Pharmacol Exp Ther; 2006 Nov; 319(2):622-31. PubMed ID: 16914561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effect of taurohyodeoxycholic acid from Pulvis Fellis Suis on trinitrobenzene sulfonic acid induced ulcerative colitis in mice.
    He J; Liang J; Zhu S; Zhao W; Zhang Y; Sun W
    Eur J Pharmacol; 2011 Nov; 670(1):229-35. PubMed ID: 21925164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex steroid regulation of macrophage migration inhibitory factor in normal and inflamed colon in the female rat.
    Houdeau E; Moriez R; Leveque M; Salvador-Cartier C; Waget A; Leng L; Bueno L; Bucala R; Fioramonti J
    Gastroenterology; 2007 Mar; 132(3):982-93. PubMed ID: 17324399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of glycolipid biosynthesis by N-(5-adamantane-1-yl-methoxy-pentyl)-deoxynojirimycin protects against the inflammatory response in hapten-induced colitis.
    Shen C; Bullens D; Kasran A; Maerten P; Boon L; Aerts JM; Van Assche G; Geboes K; Rutgeerts P; Ceuppens JL
    Int Immunopharmacol; 2004 Jul; 4(7):939-51. PubMed ID: 15182733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amelioration of immune-mediated experimental colitis: tolerance induction in the presence of preexisting immunity and surrogate antigen bystander effect.
    Gotsman I; Shlomai A; Alper R; Rabbani E; Engelhardt D; Ilan Y
    J Pharmacol Exp Ther; 2001 Jun; 297(3):926-32. PubMed ID: 11356912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.